Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
125.05B | 126.44B | 118.05B | 114.25B | 146.93B | 145.16B | Gross Profit |
34.12B | 31.74B | 31.91B | 32.41B | 64.79B | 62.03B | EBIT |
9.89B | 7.78B | 8.62B | 9.45B | 7.24B | 7.15B | EBITDA |
13.29B | 12.82B | 10.06B | 13.27B | 14.13B | 11.05B | Net Income Common Stockholders |
8.40B | 6.72B | 6.22B | 6.22B | 6.65B | 4.32B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
14.19B | 22.08B | 25.25B | 26.59B | 23.05B | 19.01B | Total Assets |
143.09B | 140.23B | 128.98B | 125.41B | 120.04B | 109.53B | Total Debt |
25.63B | 28.09B | 33.69B | 34.58B | 35.26B | 31.43B | Net Debt |
11.44B | 6.04B | 8.45B | 7.99B | 12.21B | 12.42B | Total Liabilities |
63.89B | 67.54B | 69.08B | 70.27B | 72.36B | 65.91B | Stockholders Equity |
79.20B | 72.69B | 59.90B | 55.14B | 47.68B | 43.62B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.54B | 2.87B | 4.42B | 405.00M | -1.61B | Operating Cash Flow |
0.00 | 4.62B | 8.17B | 11.31B | 12.16B | 5.25B | Investing Cash Flow |
0.00 | 843.00M | -5.74B | -6.58B | -11.21B | -6.23B | Financing Cash Flow |
0.00 | -4.42B | -2.90B | -1.32B | 3.11B | 1.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥267.86B | 17.01 | 1.89% | 25.63% | -24.35% | ||
76 Outperform | €451.07B | 16.02 | 9.19% | 1.70% | 5.92% | 56.91% | |
74 Outperform | $1.37T | 21.73 | 12.17% | 1.70% | 7.29% | 9.77% | |
74 Outperform | $3.32T | 47.53 | 8.89% | 1.16% | 8.76% | -0.23% | |
73 Outperform | $272.43B | 21.20 | 4.20% | 1.67% | 6.21% | -25.51% | |
65 Neutral | ¥72.93B | 8.96 | 1.43% | 0.27% | 64.09% | ||
64 Neutral | $8.77B | 14.68 | 4.78% | 173.90% | 3.25% | 2.18% |